Epithelioid hemangioma is an unusual vascular tumor, only recently accepted as an entity in bone1,2. It is generally considered a benign lesion; however, there have been reports describing cortical destruction and local soft-tissue invasion2-4, particularly when affecting small tubular bones. It can affect patients of any age, has no sex preponderance, and usually presents with localized pain. Although the etiology in bone is unknown, allergic reactions, trauma, and autoimmune processes have been implicated in the pathogenesis of the soft-tissue variant of this tumor5,6. We report a case of epithelioid hemangioma in the proximal part of the tibia of a fifty-three-year-old man, which occurred soon after total knee arthroplasty. To our knowledge, this is the first reported case of this type of lesion associated with an implanted prosthesis. The patient was informed that data concerning the case would be submitted for publication, and he provided consent.
A fifty-two-year-old man with no relevant medical history underwent an uneventful right-sided total knee arthroplasty for symptomatic osteoarthritis. The preoperative (Fig. 1-A) and immediately postoperative radiographs (Fig. 1-B) did not reveal any osseous lesion, and the tibia and femur both appeared to be normal during surgery. Six weeks later, he returned to the clinic prepared to undergo the same operation on the left side, which was subsequently successfully undertaken.
Five months following the right-sided total knee arthroplasty, the patient reported discomfort in the upper medial aspect of the tibia. On examination, he had a good range of knee motion, and he was systemically well. Blood tests showed no signs of infection, and given his activity of cycling thirty-five miles and walking two and one-half miles daily, a clinical diagnosis of pes anserine bursitis was made. Nevertheless, radiographs were obtained (Fig. 1-C).
One month later, the patient returned to the clinic, and although the tibial tenderness had improved, the radiographs had revealed osseous resorption with cortical destruction of the proximal part of the medial aspect of the tibia (Fig. 1-C). As reported by a musculoskeletal radiologist, the magnetic resonance imaging (MRI) most likely showed a periprosthetic infection (Figs. 2-A and 2-B).
A small open biopsy was performed in the operating room under fluoroscopic guidance, and a specimen from the medial aspect of the tibia was sent for microbiological and histological analysis. Cultures revealed growth of coagulase-negative Staphylococcus epidermidis. Histologic findings demonstrated hemorrhagic granulation with a scattered population of mixed inflammatory cells, including polymorphonuclear leukocytes, which indicated a low-grade infection. There was no evidence of a hemangioma at this stage. Results of laboratory tests revealed a C-reactive protein level of 17 mg/L (normal range, <6 mg/L), an erythrocyte sedimentation rate of 28 mm/h (normal range, 1 to 35 mm/h), and a white blood-cell count within normal limits.
After discussion with orthopaedic colleagues and because of a likely infective process, we decided to perform a two-stage revision arthroplasty. The first stage took place six months after the primary joint replacement. Intraoperatively, the medial part of the tibial plateau macroscopically appeared to be replaced by a loculated, firm, organized hematoma that was densely attached to the surrounding soft tissue (Fig. 3). This was all removed and sent for histological analysis, and an antibiotic cement spacer was placed in situ. The patient was started on parenteral antibiotics, followed by oral antibiotics. Microscopic evaluation of the intraoperative specimens revealed no neutrophils. Microbiological cultures of the specimens revealed no growth of organisms. Histologic analysis showed an expanded synovium with a hemorrhagic appearance that showed a proliferation of small capillaries, the features of which were initially described as representing an organizing hematoma (Fig. 4). Evidence of an acute inflammatory process was not seen. The diagnosis from the local histopathology department was unclear, so the specimen was sent to the national bone tumor unit, which provided a diagnosis of epithelioid hemangioma (this report was not received until after the second-stage revision had taken place).
The second stage of the joint revision took place six weeks after the first stage. The last follow-up was eighteen weeks postrevision surgery, by which time the conclusive report from the national bone tumor unit had been received. At this time, the C-reactive protein level and the erythrocyte sedimentation rate both had returned to the normal range. The patient had cycled eleven miles to the clinic and was symptom-free, constitutionally well, and had a good range of movement in both knees.
We present the case of an epithelioid hemangioma of bone that appeared within a few months of total knee replacement. To our knowledge, there are no other reports documenting a potential association between arthroplasty and the development of an epithelioid hemangioma.
Epithelioid hemangioma, previously known as angiolymphoid hyperplasia with eosinophilia or histiocytoid hemangioma, has recently been accepted into the World Health Organization Classification of Bone Tumors, placed toward the benign end of the spectrum between hemangioma (benign) and angiosarcoma (malignant)7. It is one of a group of vascular lesions characterized by large epithelioid endothelial cells that have abundant eosinophilic cytoplasm2,8-10. There have been relatively few reported cases of epithelioid hemangioma of bone, although some believe this may be because of its previous erroneous classification as a low-grade hemangioendothelial sarcoma2,10. Epithelioid hemangioma, however, is recognized as a distinct entity. It is usually a solitary lesion that is eccentrically placed when occurring in long bones and well-circumscribed with expanded bone, but it is rarely aggressive9. To date, there have been no reports of recurrence. It most commonly affects long bones2; however, when it affects small tubular bones, it can be associated with cortical destruction and local soft-tissue invasion2-4,9. Macroscopically, the tumor is described as multiloculated, reddish-brown, and hemorrhagic in appearance2-4,8-11.
In many previously reported cases, patients with epithelioid hemangioma presented with localized pain of some duration (often months)2,4,8,11. In our patient, however, the symptoms were acute. The lesion was discovered prior to implant failure because radiographs were obtained, despite a presumptive clinical diagnosis of pes anserine bursitis. Given that the initial culture report and blood tests were suggestive of infection, the correct management was undertaken. Management was aggressive and appropriate for a potentially infected joint replacement. If the histology from the initial biopsy had pointed toward a benign vascular lesion rather than infection, a single-stage revision might have been undertaken.
Associations with concurrent skin lesions2 and with pregnancy4 have been made, but the etiology for this tumor is yet to be found. In skin and soft tissues, epithelioid hemangioma has been described as inflammatory and potentially reactive rather than neoplastic5,6. In our patient, the tibia looked grossly normal during the primary joint replacement operation; therefore, no tissue removed at this stage was sent to the pathology department. All of the changes were noted five months postoperatively when the patient experienced pain.
This case highlights the need for a thorough investigation of pain that occurs following a joint replacement. Once an osteolytic lesion is demonstrated on radiographs, most common pathologies may be investigated and excluded; however, if pain is not investigated because it is transient, a benign but locally aggressive tumor, such as an epithelioid hemangioma, may lead to implant failure.
Note: We would like to thank Dr. Tim Barker and colleagues at the Department of Histopathology, Norfolk and Norwich University Hospital, and our colleagues in the Department of Histopathology at the Royal National Orthopaedic Hospital, Stanmore, for their assistance with this case report.
Bruder
E;
Perez-Atayde
AR;
Jundt
G;
Alomari
AI;
Rischewski
J;
Fishman
SJ;
Mulliken
JB;
Kozakewich
HP. Vascular lesions of bone in children, adolescents, and young adults. A clinicopathologic reappraisal and application of the ISSVA classification. Virchows Arch.
2009 Feb;454(
2):161-79. .[CrossRef]
Nielsen
GP;
Srivastava
A;
Kattapuram
S;
Deshpande
V;
O’Connell
JX;
Mangham
CD;
Rosenberg
AE. Epithelioid hemangioma of bone revisited: a study of 50 cases. Am J Surg Pathol.
2009 Feb;33(
2):270-7.[CrossRef]
Floris
G;
Deraedt
K;
Samson
I;
Brys
P;
Sciot
R. Epithelioid hemangioma of bone: a potentially metastasizing tumor?Int J Surg Pathol.
2006 Jan;14(
1):9-15; .[CrossRef]
Lamovec
J;
Bracko
M. Epithelioid hemangioma of small tubular bones: a report of three cases, two of them associated with pregnancy. Mod Pathol.
1996 Aug;9(
8):821-7.
Trindade
F;
Haro
R;
Requena
L. Giant angiolymphoid hyperplasia with eosinophilia on the chest. J Cutan Pathol.
2009 Apr;36(
4):493-6.[CrossRef]
Busquets
AC;
Sánchez
JL. Angiolymphoid hyperplasia with eosinophilia induced by trauma. Int J Dermatol.
2006 Oct;45(
10):1211-4.[CrossRef]
Verbeke
SL;
Bovée
JV. Primary vascular tumors of bone: a spectrum of entities?Int J Clin Exp Pathol.
2011 Aug 15;4(
6):541-51. .
Sung
MS;
Kim
YS;
Resnick
D. Epithelioid hemangioma of bone. Skeletal Radiol.
2000 Sep;29(
9):530-4.[CrossRef]
Wenger
DE;
Wold
LE. Benign vascular lesions of bone: radiologic and pathologic features. Skeletal Radiol.
2000 Feb;29(
2):63-74.[CrossRef]
O’Connell
JX;
Kattapuram
SV;
Mankin
HJ;
Bhan
AK;
Rosenberg
AE. Epithelioid hemangioma of bone. A tumor often mistaken for low-grade angiosarcoma or malignant hemangioendothelioma. Am J Surg Pathol.
1993 Jun;17(
6):610-7.[CrossRef]
Ling
S;
Rafii
M;
Klein
M. Epithelioid hemangioma of bone. Skeletal Radiol.
2001 Apr;30(
4):226-9.[CrossRef]
Disclosure: None of the authors received payments or services, either directly or indirectly (i.e., via his or her institution), from a third party in support of any aspect of this work. None of the authors, or their institution(s), have had any financial relationship, in the thirty-six months prior to submission of this work, with any entity in the biomedical arena that could be perceived to influence or have the potential to influence what is written in this work. Also, no author has had any other relationships, or has engaged in any other activities, that could be perceived to influence or have the potential to influence what is written in this work. The complete Disclosures of Potential Conflicts of Interest submitted by authors are always provided with the online version of the article.